Abstract | OBJECTIVES: METHODS: E. coli BL21 (DE3) PlysS (E. coli) was used to express CUS245C with a cysteine residue inserting to the C-terminus of Cucurmosin. Then immobilized metal ion affinity chromatography ( IMAC) was used to purify CUS245C. The chemical conjugation method was used for the preparation of C-CUS245C. Then dialysis and IMAC were used to purify C-CUS245C. Western blot as well as SDS-PAGE was carried out to characterize the formation of C-CUS245C. At last the anti- colorectal cancer activity of C-CUS245C was investigated in vitro and in vivo. RESULTS: CUS245C with high purity could be obtained from the prokaryotic system. C-CUS245C was successfully constructed and highly purified. The cytotoxicity assays in vitro showed a significant proliferation inhibition of C-CUS245C on EGFR-positive cells for 120 h with IC50 values less than 0.1 pM. Besides, the anti- tumor efficacy of C-CUS245C was remarkably more potent than that of Cetuximab, CUS245C, and C + CUS245C (P < 0.001). Whereas the cytotoxicity of C-CUS245C could hardly be detected on EGFR-null cell line. Our results also showed that C-CUS245C had efficacy of anti- colorectal cancer in mouse xenograft model, indicating the therapeutic potential of C-CUS245C for the targeted therapy of colorectal neoplasms. CONCLUSIONS: C-CUS245C exhibits potent and EGFR-specific cytotoxicity. Insertional mutagenesis technique is worthy to be adopted in the preparation of immunotoxin. Immunotoxin can be highly purified through dialysis followed by IMAC.
|
Authors | Shuifa Wu, Cuimin Deng, Caiyun Zhang, Jiani Xiong, Xiaofan Gu, Ze Wang, Jingjing Tu, Jieming Xie |
Journal | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
(Clin Transl Oncol)
Vol. 23
Issue 8
Pg. 1549-1560
(Aug 2021)
ISSN: 1699-3055 [Electronic] Italy |
PMID | 33474678
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents, Immunological
- Immunoconjugates
- Immunotoxins
- Plant Proteins
- cucurmosin protein, Cucurbita moschata
- EGFR protein, human
- ErbB Receptors
- Cetuximab
|
Topics |
- Animals
- Antineoplastic Agents, Immunological
(pharmacology)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cetuximab
(pharmacology, therapeutic use)
- Chromatography, Affinity
(methods)
- Colorectal Neoplasms
(metabolism, pathology, therapy)
- ErbB Receptors
(antagonists & inhibitors, metabolism)
- Escherichia coli
(metabolism)
- Humans
- Immunoconjugates
(chemistry, therapeutic use)
- Immunotoxins
(chemistry, isolation & purification, metabolism, therapeutic use)
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Molecular Targeted Therapy
(methods)
- Mutagenesis, Insertional
(methods)
- Plant Proteins
(chemistry, metabolism, therapeutic use)
- Time Factors
- Xenograft Model Antitumor Assays
|